Massachusetts General Hospital
Boston, Massachusetts, United States
Purpose
To evaluate in vivo escape resistance of HIV mAbs and other biologics to develop optimal products for the prevention or treatment of HIV in the world’s poorest populations.
Division
Global Health
Date
November 2025
Region Served
GLOBAL
Committed amount
$1,181,594
Grant topic
Discovery and Translational Sciences
Duration (months)
25
Grantee location
Boston, Massachusetts, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.